Molecular Pharmaceutics
[ASAP] Boosting Type‑I and Type-II ROS Production of Water-Soluble Porphyrin for Efficient Hypoxic Tumor Therapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00822
Molecular Pharmaceutics
[ASAP] Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00830
Molecular Pharmaceutics
[ASAP] Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00507
Molecular Pharmaceutics
[ASAP] Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00594
Molecular Pharmaceutics
[ASAP] Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00709
Molecular Pharmaceutics
[ASAP] <sup>18</sup>F‑5-FPN: A Specific Probe for Monitoring Photothermal Therapy Response in Malignant Melanoma
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00742
Molecular Pharmaceutics
[ASAP] Zoledronic Acid Implant Coating Results in Local Medullary Bone Growth
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00644
Molecular Pharmaceutics
[ASAP] Mechanism-Based Pharmacokinetic Modeling of Absorption and Disposition of a Deferoxamine-Based Nanochelator in Rats
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00737
Molecular Pharmaceutics
[ASAP] Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00700
Molecular Pharmaceutics
[ASAP] Dynamic Changes in Gastrointestinal Fluid Characteristics after Food Ingestion Are Important for Quantitatively Predicting the <italic toggle=”yes”>In Vivo</italic> Performance of Oral Solid Dosage Forms in Humans in the Fed State
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00666